loading
Sana Biotechnology Inc stock is traded at $3.58, with a volume of 3.67M. It is down -0.56% in the last 24 hours and down -26.49% over the past month. Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
See More
Previous Close:
$3.60
Open:
$3.65
24h Volume:
3.67M
Relative Volume:
0.68
Market Cap:
$851.35M
Revenue:
-
Net Income/Loss:
$-283.26M
P/E Ratio:
-2.4354
EPS:
-1.47
Net Cash Flow:
$-273.61M
1W Performance:
+7.51%
1M Performance:
-26.49%
6M Performance:
+18.94%
1Y Performance:
-37.30%
1-Day Range:
Value
$3.5508
$3.775
1-Week Range:
Value
$3.24
$3.775
52-Week Range:
Value
$1.26
$7.30

Sana Biotechnology Inc Stock (SANA) Company Profile

Name
Name
Sana Biotechnology Inc
Name
Phone
(206) 701-7914
Name
Address
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Name
Employee
194
Name
Twitter
Name
Next Earnings Date
2025-08-08
Name
Latest SEC Filings
Name
SANA's Discussions on Twitter

Compare SANA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SANA
Sana Biotechnology Inc
3.58 863.23M 0 -283.26M -273.61M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-03-25 Resumed Morgan Stanley Overweight
Mar-18-25 Upgrade Citizens JMP Mkt Perform → Mkt Outperform
Mar-14-25 Initiated Jefferies Buy
Jan-08-25 Upgrade TD Cowen Hold → Buy
Nov-05-24 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-26-24 Initiated Rodman & Renshaw Buy
Jan-16-24 Upgrade H.C. Wainwright Neutral → Buy
Sep-25-23 Initiated JMP Securities Mkt Outperform
Sep-05-23 Initiated Citigroup Buy
Aug-14-23 Initiated TD Cowen Market Perform
May-02-23 Initiated H.C. Wainwright Neutral
Mar-01-21 Initiated BofA Securities Buy
Mar-01-21 Initiated Goldman Neutral
Mar-01-21 Initiated JP Morgan Neutral
Mar-01-21 Initiated Morgan Stanley Overweight
View All

Sana Biotechnology Inc Stock (SANA) Latest News

pulisher
Aug 20, 2025

Sana Biotechnology Reports Q2 2025 Financial Results - TipRanks

Aug 20, 2025
pulisher
Aug 20, 2025

Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares - GlobeNewswire

Aug 20, 2025
pulisher
Aug 20, 2025

$86.3 Million Capital Raise: Sana Biotechnology Strengthens Position with Successful Share Offering Completion - Stock Titan

Aug 20, 2025
pulisher
Aug 20, 2025

Sentiment Tools Show Shift in Trader Mood on Sana Biotechnology Inc.Market Trend Review & Stepwise Entry/Exit Trade Alerts - classian.co.kr

Aug 20, 2025
pulisher
Aug 18, 2025

Sana Biotechnology Inc. Sees Spike in Bullish Option FlowJuly 2025 Trends & Verified Momentum Stock Watchlist - newsimpact.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Screener Results Flag Sana Biotechnology Inc. as Oversold2025 Buyback Activity & Comprehensive Market Scan Reports - classian.co.kr

Aug 18, 2025
pulisher
Aug 17, 2025

Quant Funds Rotate Into Sana Biotechnology Inc. Stock2025 Earnings Impact & Daily Volume Surge Signals - newsyoung.net

Aug 17, 2025
pulisher
Aug 17, 2025

What institutional flow reveals about Sana Biotechnology Inc.2025 Breakouts & Breakdowns & Intraday High Probability Alerts - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Can you recover from losses in Sana Biotechnology Inc.July 2025 Fed Impact & Community Shared Stock Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Does Sana Biotechnology Inc. qualify in momentum factor screening2025 Key Lessons & Free Real-Time Market Sentiment Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will Sana Biotechnology Inc. bounce back from current support2025 Trading Recap & AI Driven Price Predictions - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Can machine learning forecast Sana Biotechnology Inc. recoveryMarket Activity Summary & Capital Efficiency Focused Strategies - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Using flow based indicators on Sana Biotechnology Inc.Trade Exit Summary & Daily Technical Stock Forecast Reports - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Tools to assess Sana Biotechnology Inc.’s risk profileDip Buying & Free Fast Entry Momentum Trade Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

How sentiment analysis helps forecast Sana Biotechnology Inc.2025 Price Momentum & AI Based Trade Execution Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is it time to cut losses on Sana Biotechnology Inc.M&A Rumor & Stock Portfolio Risk Control - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will breakout in Sana Biotechnology Inc. lead to full recoveryJuly 2025 Drop Watch & Free Weekly Watchlist of Top Performers - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Sana Biotechnology Inc. stock trend forecastVolume Spike & Weekly Watchlist of Top Performers - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What momentum shifts mean for Sana Biotechnology Inc.July 2025 Trends & Community Consensus Trade Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Smart tools for monitoring Sana Biotechnology Inc.’s price actionEarnings Trend Report & Verified Short-Term Trading Plans - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

How to read the order book for Sana Biotechnology Inc.Market Sentiment Report & Fast Entry High Yield Stock Tips - Newser

Aug 15, 2025
pulisher
Aug 13, 2025

Sana Biotechnology's Promising Advances in Diabetes Treatment Support Buy Rating - AInvest

Aug 13, 2025
pulisher
Aug 12, 2025

Sana Biotechnology shares rise 6.34% intraday after positive clinical results and FDA meeting. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Sana Biotech Bails on Factory in Old AT&T Call Center - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

Sana Biotechnology’s Strategic Advances and Positive FDA Feedback Bolster Buy Rating - TipRanks

Aug 12, 2025
pulisher
Aug 12, 2025

Sana: Q2 Earnings Snapshot - Connecticut Post

Aug 12, 2025
pulisher
Aug 12, 2025

Is Sana Biotechnology Inc. stock a value trapGolden Crossover Alert - kangso.co.kr

Aug 12, 2025
pulisher
Aug 12, 2025

Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire

Aug 12, 2025
pulisher
Aug 11, 2025

Sana Biotechnology SANA 2025Q2 Earnings Preview Upside Expected with New Product Pipeline Developments - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Institutional Investors May Adopt Severe Steps After Sana Biotechnology, Inc.'s (NASDAQ:SANA) Latest 29% Drop Adds to a Year Losses - 富途牛牛

Aug 11, 2025
pulisher
Aug 11, 2025

Will Sana Biotechnology Inc. benefit from macro trendsFree High Yield Stock Screening Results - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Sana suspends build-out of Bothell manufacturing facility - The Business Journals

Aug 11, 2025
pulisher
Aug 11, 2025

Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of “Buy” by Brokerages - Defense World

Aug 11, 2025
pulisher
Aug 11, 2025

Is Sana Biotechnology Inc. stock poised for growthWeekly Signal Report with Trend Summary - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Sana Biotechnology: A High-Risk, High-Reward Play on a Potential Diabetes Cure - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

Reversal indicators forming on Sana Biotechnology Inc. stockSwing Trade Entry and Exit Point Analysis - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Sana Biotechnology drops 13% on $75M stock issuance, prices at $3.35 - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Sana Biotechnology options signal 10.8% potential stock price movement after earnings - AInvest

Aug 09, 2025
pulisher
Aug 08, 2025

Sana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program Prospects - MSN

Aug 08, 2025
pulisher
Aug 08, 2025

Sana Biotechnology Announces Public Offering Pricing - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued (NASDAQ:SANA) - Seeking Alpha

Aug 08, 2025
pulisher
Aug 08, 2025

Sana Biotechnology shares rise 3.03% premarket after pricing $75 million share offering. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Sana Biotechnology Announces Pricing of Public Offering - GlobeNewswire

Aug 08, 2025
pulisher
Aug 08, 2025

Seattle biotech firm Sana Biotechnology raising $75 million through public offering - The Business Journals

Aug 08, 2025
pulisher
Aug 07, 2025

Sana Biotechnology Announces $69.9mln Public Offering of 20.9mln Shares - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

ALRM shifts unused 2015 shares to 2025 equity plan; no new dilution | SANA SEC FilingForm 8-K - Stock Titan

Aug 07, 2025
pulisher
Aug 07, 2025

Sana Biotechnology (SANA.O) Plummets 28% – What’s Behind the Sudden Drop? - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Sana Biotechnology Plummets 30.5% Intraday: A Technical and Order-Flow Deep Dive - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Sana Biotechnology Plummets 30%: A Bearish Storm Unfolds as Capital Raise Sparks Investor Exodus - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Sana Biotechnology stock tumbles after pricing public offering By Investing.com - Investing.com Canada

Aug 07, 2025
pulisher
Aug 07, 2025

Sana Biotechnology stock tumbles after pricing public offering - Investing.com

Aug 07, 2025

Sana Biotechnology Inc Stock (SANA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Sana Biotechnology Inc Stock (SANA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Cassidy Bernard J
EVP & General Counsel
Mar 07 '25
Option Exercise
0.00
11,041
0
115,823
Harr Steve
President & CEO
Mar 07 '25
Option Exercise
0.00
50,000
0
7,889,750
Wyrick Susan D.
See Remarks
Mar 02 '25
Option Exercise
0.00
1,525
0
155,471
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):